MALAT1 and neoplasm: As expected after the discovery of the first lncRNAs in cancer like H19, MALAT1, PCA3, the list of lncRNAs involved in tumor progression and metastasis is growing and their role as prognostic biomarkers and as prominent therapeutic targets in tumor patients is becoming increasingly more evident [141,142,143].